Business Context and Reporting Period
This Form 6-K filing by Novo Nordisk A/S is dated May 12, 2026. The report serves as a disclosure of transactions in Novo Nordisk shares by board members, executives, and their associated persons, in compliance with Article 19 of Regulation No. 596/2014 on market abuse. The company is a leading global healthcare firm headquartered in Denmark, employing approximately 67,900 people across 80 countries.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly limited to reporting specific insider transactions.
Material Changes and Transaction Details
The filing discloses two specific transactions occurring on May 7, 2026, involving shares received as gifts by persons closely associated with Karsten Munk Knudsen, Executive Vice President and Chief Financial Officer (CFO). Both transactions took place outside a trading venue.
- Transaction 1:
- Recipient: Caroline Munk Esbjerg (Closely associated person to CFO).
- Volume: 50 shares.
- Price: DKK 294.30 per share.
- Total Value: DKK 14,715.
- Transaction 2:
- Recipient: Sofie Munk Esbjerg (Closely associated person to CFO).
- Volume: 50 shares.
- Price: DKK 294.25 per share.
- Total Value: DKK 14,712.50.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It is a regulatory notification of share ownership changes.
Key Facts for Investor Verification
- Verify the relationship of the recipients (Caroline Munk Esbjerg and Sofie Munk Esbjerg) to the CFO, Karsten Munk Knudsen.
- Confirm the nature of the transaction as "Shares received as gift" rather than a market purchase or sale.
- Note the transaction date (May 7, 2026) and the filing date (May 12, 2026) to ensure compliance with reporting timelines.
- Observe the share price at the time of the gift (approx. DKK 294.25–294.30) for context against current market prices.